Search

Physician-scientist James Fagin focuses on the pathogenesis of thyroid cancer and the role of oncogenic kinases.

I completed my PhD at the University of Pennsylvania in the Biochemistry and Molecular Biophysics program where I employed synthetic chemistry and cell engineering to develop molecular tools for applications in nuclear medicine, such as Positron Emission Tomography (PET) imaging probes, small-molecule radiotherapies, as well as a molecular tool for targeted protein degradation. Currently, I am interested in studying mechanisms of cancer metastasis initiation and outgrowth.